8POI image
Entry Detail
PDB ID:
8POI
Title:
Molecular Docking of SPF30 Tudor domain with synthetic inhibitor 4-(pyridin-2-yl)thiazol-2-amine
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-07-04
Release Date:
2023-08-23
Method Details:
Experimental Method:
Conformers Calculated:
400
Conformers Submitted:
4
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Survival of motor neuron-related-splicing factor 30
Chain IDs:A
Chain Length:64
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Pharmacological perturbation of the phase-separating protein SMNDC1.
Nat Commun 14 4504 4504 (2023)
PMID: 37587144 DOI: 10.1038/s41467-023-40124-0

Abstact

SMNDC1 is a Tudor domain protein that recognizes di-methylated arginines and controls gene expression as an essential splicing factor. Here, we study the specific contributions of the SMNDC1 Tudor domain to protein-protein interactions, subcellular localization, and molecular function. To perturb the protein function in cells, we develop small molecule inhibitors targeting the dimethylarginine binding pocket of the SMNDC1 Tudor domain. We find that SMNDC1 localizes to phase-separated membraneless organelles that partially overlap with nuclear speckles. This condensation behavior is driven by the unstructured C-terminal region of SMNDC1, depends on RNA interaction and can be recapitulated in vitro. Inhibitors of the protein's Tudor domain drastically alter protein-protein interactions and subcellular localization, causing splicing changes for SMNDC1-dependent genes. These compounds will enable further pharmacological studies on the role of SMNDC1 in the regulation of nuclear condensates, gene regulation and cell identity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures